Invetx
Boston, US · Founded 2018 · Delaware corporation · 3 known investors
Founders & leadership
JH
Jurgen HornNamed on SEC filing
Board
PA
Investors · 3
Reported raises · per SEC filings
Form D private placements$70.7M disclosed across 2 rounds · 2020–2022
▶$55.5MraisedApr 2022 · 10 investors · BiotechnologyRule 506(b)
▶$55.5MraisedApr 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- PETER LEEDirector
- JURGEN HORNExecutive Officer, Director
- JASON AKUSDirector
- PHILIP AUSTINDirector
- JOACHIM HASENMAIERDirector
- Offering amount
- $55.5M
- Amount sold
- $55.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$15.3MraisedMar 2020 · 2 investors · OtherRule 506(b)
▶$15.3MraisedMar 2020 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jurgen HornExecutive Officer, Director
- Philip AustinDirector
- Offering amount
- $15.3M
- Amount sold
- $15.3M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Invetx's investors?
- Invetx's investors include F-Prime Capital, GV (Google Ventures), Anterra Capital.
- How much funding has Invetx raised?
- Invetx has disclosed $70.7M raised across 2 rounds.
- Where is Invetx headquartered?
- Invetx is headquartered in Boston, US.